Hawaii SR 13: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF KETAMINE THERAPY TO TREAT DEPRESSION.

Status: The committee on CPN deferred the measure. (as of 2023-03-16)

State: Hawaii · Session: 2023 Regular Session · Bill: SR 13

Subjects: Auditor, Health, Insurance, Ketamine Therapy, Medicaid, Report

Sponsors: FEVELLA

View Hawaii SR 13 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.